Skip to main content

Prof. Dr. Tanja Schneider

Member

Institute for Pharmaceutical Microbiology

University Clinic Bonn University of Bonn Meckenheimer Allee 168 53115 Bonn

tschneider@uni-bonn.de

+49 228 735688

Website

  • Mode of action studies on novel antibiotics (e.g. teixobactin, plectasin, lipopeptides)
  • Identification of new antibiotic targets and screening• Antibiotic resistance mechanisms
  • Investigations on bacterial cell envelope biosynthesis, particularly peptidoglycan, wall teichoic acid and capsule biosynthesis
  • Regulation of cell envelope biosynthesis and modification• Additional antiinfective strategies – Antivirulence and combination therapy
  • Screening technologies

Recent publications

  • Synthesis of Bisindole Alkaloids and Their Mode of Action against Methicillin-Resistant .

    ACS infectious diseases

    Authors: Emmanuel T Adeniyi, Marco Kruppa, Stefania De Benedetti, Kevin C Ludwig, Violetta Krisilia, Tobias R Wassenberg, Melissa Both, Tanja Schneider, Thomas J J Müller, Rainer Kalscheuer

    View this publication
  • The MraY Inhibitor Muraymycin D2 and Its Derivatives Induce Enlarged Cells in Obligate Intracellular and and Break the Persistence Phenotype in .

    Antibiotics (Basel, Switzerland)

    Authors: Iris Löckener, Lara Vanessa Behrmann, Jula Reuter, Andrea Schiefer, Anna Klöckner, Sebastian Krannich, Christian Otten, Katja Mölleken, Satoshi Ichikawa, Achim Hoerauf, Tanja Schneider, Kenneth M Pfarr, Beate Henrichfreise

    View this publication
  • Staphylococcus epidermidis bacteriocin A37 kills natural competitors with a unique mechanism of action.

    The ISME journal

    Authors: Jan-Samuel Puls, Benjamin Winnerling, Jeffrey John Power, Annika Marie Krüger, Dominik Brajtenbach, Matthew Johnson, Kevser Bilici, Laura Camus, Thomas Fließwasser, Tanja Schneider, Hans-Georg Sahl, Debnath Ghosal, Ulrich Kubitscheck, Simon Heilbronner, Fabian Grein

    View this publication